Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Prinz

Showing results (401-410 of 456) with videos related to

Pageof 46
Sort By:
Blood Advances|March 31, 2025
AhR activation mitigates graft-versus-host disease of the central nervous system by reducing microglial NF-κB signalingAlexander Zähringer, Inês Morgado, Daniel Erny, et al.
Nature Communications|December 1, 2020
Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer's diseaseMarta Olah, Vilas Menon, Naomi Habib, et al.
Science Translational Medicine|June 12, 2024
Anti-PD-1 cancer immunotherapy induces central nervous system immune-related adverse events by microglia activationJanaki Manoja Vinnakota, Rachael C Adams, Dimitrios Athanassopoulos, et al.
Brain : a Journal of Neurology|August 25, 2025
Mutual reinforcement of lymphotoxin-driven myositis and impaired autophagy in murine muscleJuliane Bremer, Judith Nagel, Jana Zschüntzsch, et al.
Nature Communications|May 24, 2018
A20 critically controls microglia activation and inhibits inflammasome-dependent neuroinflammationSofie Voet, Conor Mc Guire, Nora Hagemeyer, et al.
Acta Neuropathologica|December 30, 2021
Oligosarcomas, IDH-mutant are distinct and aggressiveAbigail K Suwala, Marius Felix, Dennis Friedel, et al.
The Journal of Clinical Investigation|May 29, 2014
Lineage-specific splicing of a brain-enriched alternative exon promotes glioblastoma progressionRoberto Ferrarese, Griffith R Harsh, Ajay K Yadav, et al.
Brain : a Journal of Neurology|April 14, 2020
NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patientsSunny Malhotra, Carme Costa, Herena Eixarch, et al.
The Journal of Experimental Medicine|June 22, 2016
Human USP18 deficiency underlies type 1 interferonopathy leading to severe pseudo-TORCH syndromeMarije E C Meuwissen, Rachel Schot, Sofija Buta, et al.
Journal of Hepatology|June 30, 2020
Reduced mitochondrial resilience enables non-canonical induction of apoptosis after TNF receptor signaling in virus-infected hepatocytesSandra Lampl, Marianne K Janas, Sainitin Donakonda, et al.
Pageof 46

Showing results (401-410 of 456) with videos related to

Sort By:
Pageof 46
Blood Advances|March 31, 2025
AhR activation mitigates graft-versus-host disease of the central nervous system by reducing microglial NF-κB signalingAlexander Zähringer, Inês Morgado, Daniel Erny, et al.
Nature Communications|December 1, 2020
Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer's diseaseMarta Olah, Vilas Menon, Naomi Habib, et al.
Science Translational Medicine|June 12, 2024
Anti-PD-1 cancer immunotherapy induces central nervous system immune-related adverse events by microglia activationJanaki Manoja Vinnakota, Rachael C Adams, Dimitrios Athanassopoulos, et al.
Brain : a Journal of Neurology|August 25, 2025
Mutual reinforcement of lymphotoxin-driven myositis and impaired autophagy in murine muscleJuliane Bremer, Judith Nagel, Jana Zschüntzsch, et al.
Nature Communications|May 24, 2018
A20 critically controls microglia activation and inhibits inflammasome-dependent neuroinflammationSofie Voet, Conor Mc Guire, Nora Hagemeyer, et al.
Acta Neuropathologica|December 30, 2021
Oligosarcomas, IDH-mutant are distinct and aggressiveAbigail K Suwala, Marius Felix, Dennis Friedel, et al.
The Journal of Clinical Investigation|May 29, 2014
Lineage-specific splicing of a brain-enriched alternative exon promotes glioblastoma progressionRoberto Ferrarese, Griffith R Harsh, Ajay K Yadav, et al.
Brain : a Journal of Neurology|April 14, 2020
NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patientsSunny Malhotra, Carme Costa, Herena Eixarch, et al.
The Journal of Experimental Medicine|June 22, 2016
Human USP18 deficiency underlies type 1 interferonopathy leading to severe pseudo-TORCH syndromeMarije E C Meuwissen, Rachel Schot, Sofija Buta, et al.
Journal of Hepatology|June 30, 2020
Reduced mitochondrial resilience enables non-canonical induction of apoptosis after TNF receptor signaling in virus-infected hepatocytesSandra Lampl, Marianne K Janas, Sainitin Donakonda, et al.
Pageof 46